Subjects - Business

Investment Bankers can be a useful resource for raising Venture Capital. Most Investment Bankers have years of experience wit

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

h funding private and public companies. Most of them are former brokers that worked on Wall Street. They usually have a wealth of kn

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

wledge and experience. They should have significant contacts that they developed over the years. It is for these reasons that you should ne

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

twork with Investment Bankers. Even if you don’t use them for your first round of funding, you may be able to use them later on as y

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ur company grows and evolves.

I have worked with many Investment Banking Firms over the years. They have either been client

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

of mine or I have represented private companies using them to raise funding. In addition to raising capital for companies, they are also t

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

remendous Deal Makers. Networking with them is important to your venture capital raising efforts.

They love to put deals

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

together. All types of deals, including raising Venture Capital, Private Placements, Mergers, Acquisitions, second round financing, IPOs, S

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

inoffs and more. After all that is how they get paid, by closing deals. You just have to convince them to get funding for your deal. As w

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ith any business segment however, there are good professionals and bad professionals.

You have to be a little selective and conduct some d

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

e diligence on Investment Bankers you talk with. Be extremely careful of any firms that ask for an “upfront fee.” It is one o

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

the oldest scams around. I strongly suggest you do not pay anyone an “upfront fee.”

If they ask for payment of expenses,

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

such as travel, make sure they are agreed to in advance and itemized. Asking for an upfront fee when they also get a commission is a good i

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

dication that they may not be that successful in actually raising money. I always advise clients to stay away from groups that ask for upfr

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

nt fees.

Investment Banking Firms can be extremely helpful in providing you with services besides just raising capital. They may re

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

view your Business Plan and give you some very important comments. These comments can be the difference that gets your foot in the door wit

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

some important funding sources.

Some Venture Capital Firms and other funding sources rely on Investment Bankers to source

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

eals for them. They rely on them to screen deals because there are just too many deals for them to review all of them. This is a valuable

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

service and of course the Investment Banking Firm has to get compensated for this service. Generally they charge 10% of the amount raised a

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

d about 10% in stock. If they can raise you the financing you need it is a fair value for the services and support they can provide.

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.subjects.org.ua/article/31928/subjects-Raising-Capital-Through-Investment-Bankers.html">Raising Capital Through Investment Bankers</a>

BB link (for phorums):
[url=http://www.subjects.org.ua/article/31928/subjects-Raising-Capital-Through-Investment-Bankers.html]Raising Capital Through Investment Bankers[/url]

Dr. Mike Beitler talk about the lost art of employee placement. He explains why companies need to develop better strategies for talent management if they want to remain competitive in today's changing business atmosphere.

Many of my carpet cleaning peers were complaining about how slow it was for them during the winter months. So I put together what has become known as the “Paul Douglas Action Plan”. I took the 13 steps outlined in this plan and modified it to fit any business that needs to blast out of a slow season slump. Take the steps outlined in this article to bust out of your slump today.

If your marketing isn't producing calls weekly from different realtors begging to use your services, learn the power of positioning to change that.

Tags

Links

Subjects - Raising Capital Through Investment Bankers

Related Articles: